Other terms
Autoimmune Lymphoproliferative Syndromes,Lymphoproliferative Syndrome, Autoimmune,Lymphoproliferative Syndromes, Autoimmune,Syndrome, Autoimmune Lymphoproliferative,Syndromes, Autoimmune Lymphoproliferative,Canale Smith Syndrome,Syndrome, Canale Smith,Autoimmune Lymphoproliferative Syndrome Type 2B,Caspase 8 Deficiency,Caspase 8 Deficiencies,Deficiencies, Caspase 8,Deficiency, Caspase 8,Caspase-8 Deficiency,Caspase-8 Deficiencies,Deficiencies, Caspase-8,Deficiency, Caspase-8,Autoimmune Lymphoproliferative Syndrome Type 2B (ALPS2B),Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant
Description
Autoimmune Lymphoproliferative Syndrome: Rare congenital lymphoid disorder due to mutations in certain Fas-Fas ligand pathway genes. Known causes include mutations in FAS, TNFSF6, NRAS, CASP8, and CASP10 proteins. Clinical features include LYMPHADENOPATHY; SPLENOMEGALY; and AUTOIMMUNITY.
Pervious tree
Next tree
Other locations in tree
Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.